{"transactions":[{"id":4636457,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Restated Warrant (right to buy)","published_at":"2026-10-06T22:11:53.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":458,"price":1.5,"value":687.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement, issued in connection with the assumption of a portion of an assigned commitment pursuant to the Amendment.  The Reporting Person also holds a previously-reported separate Prepayment Restated Warrant that was issued on May 29, 2026, subject to the same vesting provision set forth in footnote (3) immediately below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vesting (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2027, in accordance with the Loan Agreement."}],"balance_after":458,"derivative":{"exercise_price":1.5,"exercise_date":"2026-10-06","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":458},"source":{"system":"sec-edgar","filing":"0001437749-26-032249","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674752/000143774926032249/rdgdoc.xml","form_type":"4"}},{"id":4636456,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Second Restated Warrant (right to buy)","published_at":"2026-10-06T22:11:53.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":1.5,"value":6750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Commitment, Origination Restated Second, and Capital Restate Second Warrants issued in connection with the assumption of a portion of an assigned funding commitment pursuant to the Assignment, Joinder, and Amendment No. 1 dated October 6, 2026 among the Issuer, the Reporting Person, and the other parties thereto (the \"Amendment\"), relating to the Amended and Restated Loan and Security Agreement dated May 29, 2026 (the \"Loan Agreement\").  The Reporting Person also holds a previously reported separate Second Restated Warrant that was issued and become exercisable on May 29, 2026."}],"balance_after":4500,"derivative":{"exercise_price":1.5,"exercise_date":"2026-10-06","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001437749-26-032249","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674752/000143774926032249/rdgdoc.xml","form_type":"4"}},{"id":719165,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to purchase common stock","published_at":"2026-07-03T01:00:41.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options fully vest as of June 30, 2027."}],"balance_after":30000,"derivative":{"exercise_price":1.01,"exercise_date":"2027-06-30","expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-022664","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022664/rdgdoc.xml","form_type":"4"}},{"id":719164,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to purchase common stock","published_at":"2026-07-03T01:00:41.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"15,000 options exercisable on 07/01/2016 and 25,000 options exercisable on 01/01/2017."}],"balance_after":0,"derivative":{"exercise_price":1,"exercise_date":"2017-01-01","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-26-022664","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022664/rdgdoc.xml","form_type":"4"}},{"id":719163,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-07-03T01:00:41.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":39604,"price":1.01,"value":40000.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 396 shares of common stock on the net exercise of option to purchase 40,000 shares of common stock.  The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01."}],"balance_after":5400396,"source":{"system":"sec-edgar","filing":"0001437749-26-022664","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022664/rdgdoc.xml","form_type":"4"}},{"id":719162,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-07-03T01:00:41.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":1,"value":40000.0,"ownership":{"direct":true},"balance_after":5440000,"source":{"system":"sec-edgar","filing":"0001437749-26-022664","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022664/rdgdoc.xml","form_type":"4"}},{"id":755769,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Restated Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":7333,"price":1.5,"value":10999.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"kind","element":"transactionCoding","label":"F5","text":"Previously issued Prepayment Warrants cancelled for Prepayment Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Loan Agreement."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Vesting (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-05-29","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755768,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Second Restated Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":1.5,"value":26250.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"kind","element":"transactionCoding","label":"F4","text":"Previously issued Second Warrants cancelled for Second Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Amended and Restated Loan and Security Agreement dated May 29, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vesting (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755767,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7516,"price":1.5,"value":11274.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"kind","element":"transactionCoding","label":"F5","text":"Previously issued Prepayment Warrants cancelled for Prepayment Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Loan Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":7516},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755766,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Second Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36750,"price":1.5,"value":55125.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents Origination Restated Second and Capital Restated Second Warrants."},{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"kind","element":"transactionCoding","label":"F4","text":"Previously issued Second Warrants cancelled for Second Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Amended and Restated Loan and Security Agreement dated May 29, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":36750},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755765,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Interim Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":17450,"price":1.5,"value":26175.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Origination Interim and Capital Interim Warrants."},{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":17450,"derivative":{"exercise_price":1.5,"exercise_date":"2026-05-29","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":17450},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755763,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Warrant (right to buy)","published_at":"2026-06-03T01:49:53.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":7516,"price":1.5,"value":11274.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Will vest (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":7516},"source":{"system":"sec-edgar","filing":"0001437749-26-019244","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019244/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-01-26"}},{"id":755762,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Second Warrant (right to buy)","published_at":"2026-06-03T01:49:53.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":36750,"price":1.5,"value":55125.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"This Form 4 amendment corrects the name of warrant issued in the form of an integrated Second Warrant, which represents Origination Second Capital Second Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Will vest (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan and Security Agreement dated January 21, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":36750},"source":{"system":"sec-edgar","filing":"0001437749-26-019244","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019244/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-01-26"}},{"id":755761,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Initial Warrant (right to buy)","published_at":"2026-06-03T01:49:53.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":30050,"price":1.5,"value":45075.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 amendment corrects the name of warrant issued in the form of an integrated Initial Warrant, which represents Commitment Initial, Origination Initial, and Capital Initial Warrants immediately exercisable for an aggregate of 30,050 shares of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 amendment corrects the name of warrant issued in the form of an integrated Initial Warrant, which represents Commitment Initial, Origination Initial, and Capital Initial Warrants immediately exercisable for an aggregate of 30,050 shares of Common Stock."}],"balance_after":30050,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":30050},"source":{"system":"sec-edgar","filing":"0001437749-26-019244","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019244/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-01-26"}},{"id":931389,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":7516,"price":1.5,"value":11274.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will vest (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement.\n\n\nThe Board of Directors of Issuer and Non-Employee Directors approved the Loan Agreement and issuance of warrants and shares of Common Stock issuable thereunder"}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":7516},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931388,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Capital Second Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":1.5,"value":52500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan and Security Agreement dated January 21, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931387,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Origination Second Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":1.5,"value":2625.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan and Security Agreement dated January 21, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931386,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Capital Initial Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":26667,"price":1.5,"value":40000.5,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":26667},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931385,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Origination Initial Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":1333,"price":1.5,"value":1999.5,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931384,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Commitment Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":2050,"price":1.5,"value":3075.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":2050},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":1077845,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-08-01T22:07:43.000Z","date":"2025-07-30","kind":"grant","planned":false,"acquired":true,"shares":3946,"price":1.5,"value":5919.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":5400000,"source":{"system":"sec-edgar","filing":"0001437749-25-024429","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024429/rdgdoc.xml","form_type":"4"}},{"id":1360085,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2022-03-04","kind":"exercise","planned":false,"acquired":false,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":33334},"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360084,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2018-12-31","kind":"exercise","planned":false,"acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360083,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":121875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-09","underlying":"Common Stock","underlying_shares":121875},"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360082,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":true,"shares":33334,"price":0.5,"value":16667.0,"ownership":{"direct":true},"balance_after":5396054,"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360081,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":true,"shares":62500,"price":0.4,"value":25000.0,"ownership":{"direct":true},"balance_after":5362720,"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360080,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":true,"shares":121875,"price":0.4,"value":48750.0,"ownership":{"direct":true},"balance_after":5300220,"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1450697,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-07-22T22:55:22.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0.33,"value":13200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options fully vest on one year anniversary of grant."}],"balance_after":40000,"derivative":{"exercise_price":0.33,"exercise_date":"2025-07-17","expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-24-023226","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924023226/rdgdoc.xml","form_type":"4"}},{"id":1507609,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-21T19:11:55.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0.75,"value":101250.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":5178345,"source":{"system":"sec-edgar","filing":"0001437749-24-017813","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924017813/rdgdoc.xml","form_type":"4"}},{"id":1703659,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-20T19:03:10.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0.5,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":5043345,"source":{"system":"sec-edgar","filing":"0001437749-23-034980","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774923034980/rdgdoc.xml","form_type":"4"}},{"id":1816936,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-03T20:17:11.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":2,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":4443345,"source":{"system":"sec-edgar","filing":"0001437749-23-021946","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774923021946/rdgdoc.xml","form_type":"4"}},{"id":2286886,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-05-02T16:22:16.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":100000,"price":1,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":4343345,"source":{"system":"sec-edgar","filing":"0001437749-22-010379","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922010379/rdgdoc.xml","form_type":"4"}},{"id":2290519,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2022-04-27T01:31:08.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":0.75,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-22-009787","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009787/rdgdoc.xml","form_type":"4"}},{"id":2290518,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2022-04-27T01:31:08.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Granted in settlement of compensation liability for period January 1, 2019 through April 30, 2019"}],"balance_after":33334,"derivative":{"exercise_price":0.5,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":33334},"source":{"system":"sec-edgar","filing":"0001437749-22-009787","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009787/rdgdoc.xml","form_type":"4"}},{"id":2290515,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:26:58.000Z","date":"2021-12-30","kind":"exercise","acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed canceled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price."}],"balance_after":0,"derivative":{"exercise_price":0.2,"exercise_date":"2021-12-01","expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001437749-22-009784","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009784/rdgdoc.xml","form_type":"5"}},{"id":2290514,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:26:58.000Z","date":"2021-12-06","kind":"other","acquired":false,"shares":322635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transferred to third party for no consideration"}],"balance_after":900000,"derivative":{"exercise_price":0.4,"exercise_date":"2021-12-01","expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":322635},"source":{"system":"sec-edgar","filing":"0001437749-22-009784","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009784/rdgdoc.xml","form_type":"5"}},{"id":2290513,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:26:58.000Z","date":"2021-12-01","kind":"disposition_to_issuer","acquired":false,"shares":322635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F4","text":"Cancelled in accordance with Warrant Modification Agreement  dated as of 12/01/21"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed canceled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price."}],"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2020-10-05","expiration_date":"2025-10-05","underlying":"Common Stock","underlying_shares":322635},"source":{"system":"sec-edgar","filing":"0001437749-22-009784","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009784/rdgdoc.xml","form_type":"5"}},{"id":2290512,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:26:58.000Z","date":"2021-12-01","kind":"disposition_to_issuer","acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F4","text":"Cancelled in accordance with Warrant Modification Agreement  dated as of 12/01/21"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed canceled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price."}],"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2020-10-05","expiration_date":"2025-10-05","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001437749-22-009784","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009784/rdgdoc.xml","form_type":"5"}},{"id":2290511,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:26:58.000Z","date":"2021-12-01","kind":"grant","acquired":true,"shares":1222635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F2","text":"Acquired in accordance with Warrant Modification Agreement  dated as of 12/01/21"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed canceled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price."}],"balance_after":1222635,"derivative":{"exercise_price":0.2,"exercise_date":"2021-12-01","expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":1222635},"source":{"system":"sec-edgar","filing":"0001437749-22-009784","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009784/rdgdoc.xml","form_type":"5"}},{"id":2290510,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-04-27T01:26:58.000Z","date":"2021-12-30","kind":"exercise","acquired":true,"shares":900000,"price":0.2,"value":180000.0,"ownership":{"direct":true},"balance_after":4243345,"source":{"system":"sec-edgar","filing":"0001437749-22-009784","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009784/rdgdoc.xml","form_type":"5"}},{"id":2290553,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:23:56.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F9","text":"Compensation warrants acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"}],"balance_after":900000,"derivative":{"exercise_price":0.4,"exercise_date":"2020-10-05","expiration_date":"2025-10-05","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001437749-22-009781","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009781/rdgdoc.xml","form_type":"5"}},{"id":2290552,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:23:56.000Z","date":"2020-10-05","kind":"disposition_to_issuer","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F7","text":"Cancelled in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved a recapitalization resulting in the deemed cancellation of the \"old\" warrants and the deemed grant of \"replacement\" warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Originally exercisable on 11/15/19 and 12/06/19, with expirations of 11/15/24 and 12/06/24, respectively, for 15,000 shares and 30,000 shares"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Originally exercisable on 11/15/19 and 12/06/19, with expirations of 11/15/24 and 12/06/24, respectively, for 15,000 shares and 30,000 shares"}],"balance_after":0,"derivative":{"exercise_price":0.4,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-22-009781","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009781/rdgdoc.xml","form_type":"5"}},{"id":2290551,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:23:56.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":322635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F5","text":"Acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved a recapitalization resulting in the deemed cancellation of the \"old\" warrants and the deemed grant of \"replacement\" warrants."}],"balance_after":322635,"derivative":{"exercise_price":0.4,"exercise_date":"2020-10-05","expiration_date":"2025-10-05","underlying":"Common Stock","underlying_shares":322635},"source":{"system":"sec-edgar","filing":"0001437749-22-009781","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009781/rdgdoc.xml","form_type":"5"}},{"id":2290550,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-04-27T01:23:56.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":25000,"price":0.4,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F4","text":"Purchase shares acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"}],"balance_after":3343345,"source":{"system":"sec-edgar","filing":"0001437749-22-009781","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009781/rdgdoc.xml","form_type":"5"}},{"id":2290549,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-04-27T01:23:56.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":82545,"price":0.4,"value":33018.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F3","text":"Conversion shares acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"}],"balance_after":3318345,"source":{"system":"sec-edgar","filing":"0001437749-22-009781","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009781/rdgdoc.xml","form_type":"5"}},{"id":2290548,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-04-27T01:23:56.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":300000,"price":0.4,"value":120000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F2","text":"Compensation shares acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"}],"balance_after":3235800,"source":{"system":"sec-edgar","filing":"0001437749-22-009781","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009781/rdgdoc.xml","form_type":"5"}},{"id":2290543,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:20:21.000Z","date":"2019-12-06","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F2","text":"Acquired in connection with Note Purchase Agreement dated as of November 15, 2019"}],"balance_after":45000,"derivative":{"exercise_price":0.4,"exercise_date":"2019-12-06","expiration_date":"2024-12-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-22-009778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009778/rdgdoc.xml","form_type":"5"}},{"id":2290542,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-27T01:20:21.000Z","date":"2019-11-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"shares","element":"transactionShares","label":"F2","text":"Acquired in connection with Note Purchase Agreement dated as of November 15, 2019"}],"balance_after":15000,"derivative":{"exercise_price":0.4,"exercise_date":"2019-11-15","expiration_date":"2024-11-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-22-009778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009778/rdgdoc.xml","form_type":"5"}},{"id":3710138,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-03T16:52:09.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62500,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"COMMON STOCK","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001091596-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000109159619000003/primary_doc.xml","form_type":"4"}},{"id":3846479,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-08-13T20:20:58.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":121875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":121875,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-09","underlying":"COMMON STOCK","underlying_shares":121875},"source":{"system":"sec-edgar","filing":"0001605411-18-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000160541118000005/primary_doc.xml","form_type":"4"}},{"id":4235557,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2017-08-14T19:26:29.000Z","date":"2017-08-10","kind":"purchase","acquired":true,"shares":560000,"price":0.5,"value":280000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes shares held in an IRA."}],"balance_after":2935800,"source":{"system":"sec-edgar","filing":"0001674752-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000167475217000001/primary_doc.xml","form_type":"4"}},{"id":4235556,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2017-08-14T19:26:29.000Z","date":"2017-08-10","kind":"purchase","acquired":true,"shares":1485000,"price":0.2222,"value":329967.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes shares held in an IRA."}],"balance_after":2375800,"source":{"system":"sec-edgar","filing":"0001674752-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000167475217000001/primary_doc.xml","form_type":"4"}},{"id":4493254,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2017-01-12T01:18:45.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The grant of these options was approved by the issuer's board of directors on July 1, 2016, subject to stockholder approval of the 2016 Omnibus Incentive Compensation Plan under which the options were granted. Stockholder approval was obtained by means of a written consent and the issuer filed a related Information Statement on Schedule 14C with the SEC on November 25, 2016. The stockholder approval became effective on January 9, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Of these options, 15,000 vested immediately, and 25,000 vested on 1/1/17."}],"balance_after":40000,"derivative":{"exercise_price":1,"expiration_date":"2026-07-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001144204-17-001881","document":"v456639_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000114420417001881/v456639_4.xml","form_type":"4"}}]}